Advanced search
Publication Cover
Future Microbiology Volume 6, 2011 - Issue 2
Submit an article Journal homepage
1,925
Views
13
CrossRef citations to date
0
Altmetric
Editorial

TcdB or Not TcdB: A Tale Of Two Clostridium Difficile Toxins

Glen P Carter1 Department of Microbiology,Monash University,Clayton 3800,VIC AustraliaView further author information
,
Milena M Awad1 Department of Microbiology,Monash University,Clayton 3800,VIC AustraliaView further author information
,
Michelle L Kelly1 Department of Microbiology,Monash University,Clayton 3800,VIC AustraliaView further author information
,
Julian I Rood1 Department of Microbiology,Monash University,Clayton 3800,VIC AustraliaView further author information
&
Dena Lyras1 Department of Microbiology,Monash University,Clayton 3800,VIC AustraliaCorrespondence[email protected]
View further author information
Pages 121-123 | Published online: 02 Mar 2011

Bibliography

  • Jank T , AktoriesK: Structure and mode of action of clostridial glucosylating toxins: the ABCD model.Trends Microbiol.16(5) , 222–229 (2008).
  • Voth DE , MartinezOV, BallardJD: Variations in lethal toxin and cholesterol-dependent cytolysin production correspond to differences in cytotoxicity among strains ofClostridium sordellii. FEMS Microbiol. Lett.259(2) , 295–302 (2006).
  • Busch C , SchömigK, HofmannF, AktoriesK: Characterization of the catalytic domain of Clostridium novyi α-toxin.Infect. Immun.68(11) , 6378–6383 (2000).
  • Amimoto K , NoroT, OishiE, ShimizuM: A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C.Microbiology153(Pt 4) , 1198–1206 (2007).
  • Nagahama M , OhkuboA, OdaMet al. : Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins.Infect. Immun.79(2) , 905–910 (2011).
  • Dang LH , BettegowdaC, HusoDL, KinzlerKW, VogelsteinB: Combination bacteriolytic therapy for the treatment of experimental tumors.Proc. Natl Acad. Sci. USA 18, 98(26) , 15155–15160 (2001).
  • Carter GP , AwadMM, HaoYet al. : TcsL is an essential virulence factor in Clostridium sordellii ATCC9714.Infect. Immun. DOI: doi:10.1128/IAI.00968-10 (2011) (Epub ahead of print).
  • Ballard JD : Medical microbiology: a toxin contest.Nature 7, 467(7316) , 665–666 (2010).
  • Lyras D , O‘ConnorJR, HowarthPKet al. : Toxin B is essential for virulence of Clostridium difficile.Nature458(7242) , 1176–1179 (2009).
  • Kuehne SA , CartmanST, HeapJT, KellyML, CockayneA, MintonNP: The role of toxin A and toxin B in Clostridium difficile infection.Nature 15, 467(7316) , 711–713 (2010).
  • Lyerly DM , SaumKE, MacDonaldDK, WilkinsTD: Effects of Clostridium difficile toxins given intragastrically to animals.Infect. Immun.47(2) , 349–352 (1985).
  • Drudy D , FanningS, KyneL: Toxin A-negative, toxin B-positive Clostridium difficile.Int. J. Infect. Dis.11(1) , 5–10 (2007).
  • Sebaihia M , WrenBW, MullanyPet al. : The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.Nat. Genet.38(7) , 779–786 (2006).
  • Hussain HA , RobertsAP, MullanyP: Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Δerm) and demonstration that the conjugative transposon Tn916ΔE enters the genome of this strain at multiple sites.J. Med. Microbiol.54(Pt 2) , 137–141 (2005).
  • O‘Connor JR , LyrasD, FarrowKAet al. : Construction and analysis of chromosomal Clostridium difficile mutants.Mol. Microbiol.61(5) , 1335–1351 (2006).
  • Carter GP , RoodJI, LyrasD: The role of toxin A and toxin B in Clostridium difficile-associated disease: past and present perspectives.Gut Microbes1(1) , 58–64 (2010).
  • Goulding D , ThompsonH, EmersonJ, FairweatherNF, DouganG, DouceGR: Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1.Infect. Immun.77(12) , 5478–5485 (2009).
  • Freeman J , BauerMP, BainesSDet al. : The changing epidemiology of Clostridium difficile infections.Clin. Microbiol. Rev.23(3) , 529–549 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.